Group One Trading Portfolio holdings
AUM
$3.05B
1-Year Return
3.54%
This Quarter Return
+2.44%
1 Year Return
+3.54%
3 Year Return
+10.97%
5 Year Return
+15.65%
10 Year Return
+24.6%
AUM
$3.49B
AUM Growth
+$1.35B
(+63%)
Cap. Flow
+$921M
Cap. Flow
% of AUM
26.41%
Top 10 Holdings %
Top 10 Hldgs %
15.57%
Holding
3,051
New
575
Increased
537
Reduced
431
Closed
483
Top Buys
| 1 |
Alibaba
BABA
|
+$88.3M |
| 2 |
Mastercard
MA
|
+$60.1M |
| 3 |
Li Auto
LI
|
+$43M |
| 4 |
Gilead Sciences
GILD
|
+$42.6M |
| 5 |
Workday
WDAY
|
+$39.4M |
Top Sells
| 1 |
Expedia Group
EXPE
|
+$59.7M |
| 2 |
Citigroup
C
|
+$35.9M |
| 3 |
Fiserv
FI
|
+$32.2M |
| 4 |
Exxon Mobil
XOM
|
+$31.1M |
| 5 |
Wynn Resorts
WYNN
|
+$26.1M |
Sector Composition
| 1 | Consumer Discretionary | 21.49% |
| 2 | Technology | 20.5% |
| 3 | Healthcare | 15.67% |
| 4 | Financials | 10.2% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Intuit
INTU
$183B
| $382K | ﹤0.01% |
+1,006
| New | +$382K |
|
|
SLCA
702
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $381K | ﹤0.01% |
54,255
-50,580
| -48% | -$355K |
|
|
MRNS
703
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $379K | ﹤0.01% |
31,056
+1,782
| +6% | +$21.7K |
|
|
NVEE
704
DELISTED
NV5 Global
NVEE
| $378K | ﹤0.01% |
19,208
+18,824
| +4,902% | +$370K |
|
705
The GEO Group
GEO
$3.01B
| $377K | ﹤0.01% |
+42,571
| New | +$377K |
|
706
Boston Properties
BXP
$11.7B
| $375K | ﹤0.01% |
+3,962
| New | +$375K |
|
707
iShares MSCI Australia ETF
EWA
$1.54B
| $370K | ﹤0.01% |
15,462
-6,898
| -31% | -$165K |
|
708
InMode
INMD
$949M
| $368K | ﹤0.01% |
15,482
-9,660
| -38% | -$230K |
|
709
Omega Healthcare
OHI
$12.6B
| $368K | ﹤0.01% |
10,137
+5,260
| +108% | +$191K |
|
710
Lakeland Industries
LAKE
$131M
| $364K | ﹤0.01% |
+13,367
| New | +$364K |
|
711
Equitable Holdings
EQH
$15.8B
| $363K | ﹤0.01% |
+14,182
| New | +$363K |
|
712
Madrigal Pharmaceuticals
MDGL
$9.59B
| $363K | ﹤0.01% |
3,265
-372
| -10% | -$41.4K |
|
|
IAA
713
DELISTED
IAA, Inc. Common Stock
IAA
| $361K | ﹤0.01% |
+5,552
| New | +$361K |
|
714
Kura Oncology
KURA
$709M
| $355K | ﹤0.01% |
10,855
+9,927
| +1,070% | +$325K |
|
715
Renaissance IPO ETF
IPO
$184M
| $354K | ﹤0.01% |
+5,490
| New | +$354K |
|
716
Thomson Reuters
TRI
$76.8B
| $354K | ﹤0.01% |
+4,168
| New | +$354K |
|
717
Cintas
CTAS
$81.2B
| $353K | ﹤0.01% |
+4,000
| New | +$353K |
|
|
ENZ
718
DELISTED
Enzo Biochem, Inc.
ENZ
| $353K | ﹤0.01% |
140,125
+119,899
| +593% | +$302K |
|
719
NewtekOne
NEWT
$305M
| $352K | ﹤0.01% |
17,901
| – | – |
|
720
Nucor
NUE
$32.6B
| $352K | ﹤0.01% |
+6,611
| New | +$352K |
|
|
TRVN
721
DELISTED
Trevena, Inc.
TRVN
| $351K | ﹤0.01% |
263
+128
| +95% | +$171K |
|
|
IMGN
722
DELISTED
Immunogen Inc
IMGN
| $346K | ﹤0.01% |
+53,713
| New | +$346K |
|
723
Frontline
FRO
$5.02B
| $344K | ﹤0.01% |
+55,373
| New | +$344K |
|
724
Anavex Life Sciences
AVXL
$763M
| $343K | ﹤0.01% |
63,484
+34,739
| +121% | +$188K |
|
725
Outfront Media
OUT
$3.12B
| $343K | ﹤0.01% |
+17,792
| New | +$343K |
|